CB

Cecile Bonnafous

IP Innate Pharma: 1 patents #5 of 15Top 35%
Overall (2021): #505,847 of 548,734Top 95%
1
Patents 2021

Issued Patents 2021

Patent #TitleCo-InventorsDate
11078275 Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma HÉLÈNE SICARD, RENAUD BUFFET 2021-08-03